A carregar...

Pharmacological Treatment of Alzheimer’s Disease: Is it Progressing Adequately?

INTRODUCTION: Between 1993 and 2000 four acetylcholinesterase inhibitors were marketed as a symptomatic treatment for Alzheimer’s disease (AD), as well as memantine in 2003. Current research is focused on finding drugs that favorably modify the course of the disease. However, their entrance into the...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Autor principal: Robles, Alfredo
Formato: Artigo
Idioma:Inglês
Publicado em: Bentham Open 2009
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2684708/
https://ncbi.nlm.nih.gov/pubmed/19461897
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1874205X00903010027
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!